<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>Science and Education Publishing</PublisherName>
<JournalTitle>American Journal of Medical and Biological Research</JournalTitle>
<Volume>1</Volume>
<Issue>1</Issue>
<PubDate PubStatus="epublish">
<Year>2013</Year>
<Month>05</Month>
<Day>07</Day>
</PubDate>
</Journal>
<ArticleTitle>The Anti-Inflammatory and Immunomodulatory Activity of Thymulin Peptide is NF-&#954;B-Dependent and Involves the Downregulation of I&#954;B-&#945;</ArticleTitle>
<FirstPage>41</FirstPage>
<LastPage>49</LastPage>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>John J.</FirstName>
<LastName>Haddad</LastName>
<Affiliation>Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon</Affiliation>
</Author>
<Author>
<FirstName>Lama H.</FirstName>
<LastName>Hanbali</LastName>
</Author>

</AuthorList>
<ArticleIdList>
<ArticleId IdType="pii">AJMBR2013122</ArticleId>
<ArticleId IdType="doi">10.12691/ajmbr-1-2-2</ArticleId>
</ArticleIdList>
<History>
<PubDate PubStatus="received">
<Year>2012</Year>
<Month>11</Month>
<Day>29</Day>
</PubDate>
<PubDate PubStatus="revised">
<Year>2013</Year>
<Month>04</Month>
<Day>26</Day>
</PubDate>
<PubDate PubStatus="accepted">
<Year>2013</Year>
<Month>05</Month>
<Day>07</Day>
</PubDate>
</History>
<Abstract>The immunomodulatory activity of thymulin and related analogues <i>in vivo</i> is not well characterized in the CNS. We have previously provided evidence for an anti-inflammatory potential of thymulin in downregulating proinflammatory cytokines in a NF-&#954;B-dependent mechanism<i> </i><i>in vitro</i>. Furthermore, we have shown that intracerebroventricular (ICV) treatment with thymulin in the hippocampus (HC) reduced the nuclear localization and activation of NF-&#954;B, an effect mediated by the I&#954;B-¦Á/<i>p</i>I&#954;B- ¦Á pathway <i>in vivo</i>. ICV stereotaxic injection of endotoxin (ET) differentially upregulated the nuclear translocation /expression of NF-&#954;B<SUB>1</SUB> (p50), NF-&#954;B<SUB>2</SUB> (p52), RelA (p65), RelB (p68) and c-Rel (p75) in the HC. Pretreatment with thymulin followed by ET exposure reduced the nuclear translocation of NF-&#954;B subunits. The anti-inflammatory effect of thymulin seems to be mediated via the I&#954;B-&#945; pathway since thymulin downregulated ET-induced phosphorylation of I&#954;B-&#945;. Stereotaxic pretreatment with synthetic peptide analogue of thymulin (PAT) reduced the nuclear translocation of NF-&#954;B subunits, an effect mediated by downregulating the phosphorylation of I&#954;B-&#945;. EMSA revealed dose-dependent inhibition of NF-&#954;B/DNA activation mediated by ICV ET. These results indicate that the anti-inflammatory effect of thymulin/PAT, mediated by I&#954;B-&#945;, is NF-&#954;B-dependent and involves the downregulation of the nuclear translocation of various NF-&#954;B subunits and their subcellular activation.</Abstract>
</Article>
</ArticleSet>
